OMEROS CORP Available-for-sale Securities, Equity Securities, Current
OMEROS CORP (OMER) had Available-for-sale Securities, Equity Securities, Current of $43.17 million as of 2019-03-31, per its 10-Q filed 2019-05-09.
Discontinued › Notes
us-gaap:AvailableForSaleSecuritiesEquitySecuritiesCurrent · last filed 2019-05-09
- 2019-03-31: Available-for-sale Securities, Equity Securities, Current $43.17M.
- 2018-12-31: Available-for-sale Securities, Equity Securities, Current $54.64M.
- 2018-09-30: Available-for-sale Securities, Equity Securities, Current $52.37M.
- 2018-06-30: Available-for-sale Securities, Equity Securities, Current $85.52M.
| Period end | Available-for-sale Securities, Equity Securities, Current |
|---|---|
| 2019-03-31 | $43.17M 10-Q · filed 2019-05-09 |
| 2018-12-31 | $54.64M 10-Q · filed 2019-05-09 |
| 2018-09-30 | $52.37M 10-Q · filed 2018-11-08 |
| 2018-06-30 | $85.52M 10-Q · filed 2018-08-09 |
| 2018-03-31 | $71.63M 10-Q · filed 2018-05-10 |
| 2017-12-31 | $80.36M 10-K · filed 2019-03-01 |
| 2017-09-30 | $85.79M 10-Q · filed 2017-11-09 |
| 2017-06-30 | $26.28M 10-Q · filed 2017-08-08 |
| 2017-03-31 | $32.37M 10-Q · filed 2017-05-10 |
| 2016-12-31 | $43.11M 10-K · filed 2018-03-01 |
| 2016-09-30 | $37.14M 10-Q · filed 2016-11-09 |
| 2016-06-30 | $16.65M 10-Q · filed 2016-08-09 |
| 2016-03-31 | $12.27M 10-Q · filed 2016-05-10 |
| 2015-12-31 | $26.90M 10-K · filed 2017-03-16 |
| 2015-09-30 | $34.40M 10-Q · filed 2015-11-09 |
| 2015-06-30 | $48.88M 10-Q · filed 2015-08-10 |
| 2015-03-31 | $68.62M 10-Q · filed 2015-05-11 |
| 2014-12-31 | $6.53M 10-K · filed 2016-03-15 |
| 2014-09-30 | $21.03M 10-Q · filed 2014-11-10 |
| 2014-06-30 | $35.93M 10-Q · filed 2014-08-11 |
| 2014-03-31 | $51.62M 10-Q · filed 2014-05-12 |
| 2013-12-31 | $12.72M 10-K · filed 2015-03-16 |
| 2013-09-30 | $7.85M 10-Q · filed 2013-11-07 |
| 2013-06-30 | $18.35M 10-Q · filed 2013-08-09 |
| 2013-03-31 | $12.04M 10-Q · filed 2013-05-09 |
| 2012-12-31 | $20.83M 10-K · filed 2014-03-13 |
| 2012-09-30 | $29.57M 10-Q · filed 2012-11-09 |
| 2012-03-31 | $815.00K 10-Q · filed 2012-05-10 |
| 2011-12-31 | $20.57M 10-K · filed 2013-03-18 |
| 2011-09-30 | $27.96M 10-Q · filed 2011-11-08 |
| 2011-06-30 | $32.72M 10-Q · filed 2011-08-09 |
| 2010-12-31 | $38.72M 10-K · filed 2012-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ultragenyx Pharmaceutical Inc. (RARE) | United States | $1.456B | -5.62 |
| ArriVent BioPharma, Inc. (AVBP) | United States | $1.485B | -10.25 |
| Innoviva, Inc. (INVA) | United States | $1.493B | 4.62 |
| Oric Pharmaceuticals, Inc. (ORIC) | United States | $1.367B | -8.00 |
| ANAPTYSBIO, INC (ANAB) | United States | $1.546B | -60.20 |
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| Kardigan, Inc. (KARD) | United States | $1.346B | |
| Tyra Biosciences, Inc. (TYRA) | United States | $1.337B | -12.83 |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |